Identifying Lymphoma RisksSeptember 14, 2004Little is known about the causes of lymphoma. A case-control study conducted by Professor Nikolaus Becker and Dr. Alexandra Nieters, Division of Clinical Epidemiology at the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), is looking closely at possible risk factors. First results of this German lymphoma study suggest immunological factors associated with lifestyle and environment. Too few challenges for the immune system during early childhood may possibly promote not only allergies, but also leukemias and lymphomas. Lymphoma are divided into two general types: Hodgkin's disease and non-Hodgkin's lymphomas. The latter are among the few cancers whose incidence and mortality have both increased steadily over the past 20 years. Similar to allergies, scientists are discussing a possible effect of early childhood events. According to a notion called hygiene hypothesis, reduced exposure to infectious agents early in life, typical of today's small family environment, may alter immune responsiveness in a direction which favors allergies, lymphomas or diseases. If this hypothesis is right, then growing up "on a farm" should offer a certain protection. The case-control study compared the data of over 700 patients, collected between 1999 and 2003, suffering from lymphomas (both Hodgkin's and non-Hodgkin's lymphomas) with those of 700 non-affected individuals matched for age, gender and place of residence. In detailed interviews, the investigators posed questions about demographic characteristics, lifestyle factors, medical history and occupational environment. Every study participant was requested to provide a blood sample. A first evaluation of data was restricted to demographic characteristics, exposures to animals, childhood diseases and vaccinations.
Several factors were indeed found to be associated positively or negatively with the risk of lymphoma. Thus, the chance of developing lymphoma was reduced for childhood exposures to animals (such as sheep, goats, rabbits and hares). Close contact to cattle, however, was associated with a higher risk. The positive association in the case of cattle exposure seems to be specific for this species and has been reported in previous studies from other countries. The risk of lymphoma was also reduced when participants had experienced childhood diseases (e.g. measles or pertussis) or received vaccinations (e.g. against tetanus) during childhood. In the case of tuberculosis vaccinations, however, the risk was elevated. Several previous studies on infections during childhood with respect to the lymphoma risk have yielded contradictory results. However, a reduced risk after measle infection, in particular, has been repeatedly observed. The fact that the disease is also associated with an increased allergy risk might indicate immunological commonalities in disease development. Other indicators of a rural environment and, thereby, strong microbial exposure remained negative, however. Thus, no association with the intake of raw milk was apparent. Nor was a relation to the number of people living in the household or the number of siblings (as an indicator of frequent infections during early childhood) observed. Nikolaus Becker interprets the results as follows: "The results are only partly in agreement with the so-called hygiene hypothesis. This can mean that these factors really are not pivotal in the development of lymphomas or that the indicators studied (such as the number of siblings) are inadequate. Nevertheless, environmental conditions during early childhood appear to have a long-lasting effect on the immune system, which can indeed be associated with the development of lymphomas." A second phase of data evaluation will now analyze further potential risks. Deutsches Krebsforschungszentrum | |||||||||||||||||||||
|
Related Lymphoma Current Events and Lymphoma News Articles Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract. USC researchers identify key mechanism that occurs at the inception point of many human lymphomas Researchers at the Keck School of Medicine of the University of Southern California (USC) have explained how certain key mutations occur in human lymphomas-a process that has, until now, remained a mystery. Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. New therapy prevents dangerous side effect for lymphoma patients Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. Potential breakthrough for T-Cell lymphoma patients with drug that mimics folic acid Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL). Clinical trial demonstrates safety of pre-transplant expansion of umbilical cord blood stem cells Taking blood stem cells collected from an umbilical cord into the lab and expanding their number before transplanting them to replace a patient's blood supply is as safe as a standard cord blood transplant, researchers reported today at the 50th Annual Meeting of the American Society of Hematology. From mother to daughters: A central mystery in cell division solved Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have identified a key step required for cell division in a study that could help improve therapies to treat cancer. M. D. Anderson to hold first international conference on inflammatory breast cancer The University of Texas M. D. Anderson Cancer Center will hold the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists. Novel treatments show improvements in survival and response rates for leukemia and lymphoma The use of dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the most common type of childhood cancer, may help reduce the risk of relapse. Novel therapeutic approaches may improve patient outcomes in several platelet disorders Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of platelets in the blood. More Lymphoma Current Events and Lymphoma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||